HomeCompareAKRFF vs MRK

AKRFF vs MRK: Dividend Comparison 2026

AKRFF yields 2063.98% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AKRFF wins by $13331039307.16M in total portfolio value
10 years
AKRFF
AKRFF
● Live price
2063.98%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$13331039307.22M
Annual income
$12,171,036,297,947,368.00
Full AKRFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AKRFF vs MRK

📍 AKRFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAKRFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AKRFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AKRFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKRFF
Annual income on $10K today (after 15% tax)
$175,438.60/yr
After 10yr DRIP, annual income (after tax)
$10,345,380,853,255,262.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AKRFF beats the other by $10,345,380,853,246,934.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKRFF + MRK for your $10,000?

AKRFF: 50%MRK: 50%
100% MRK50/50100% AKRFF
Portfolio after 10yr
$6665519653.64M
Annual income
$6,085,518,148,978,583.00/yr
Blended yield
91.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AKRFF
No analyst data
Altman Z
-0.2
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKRFF buys
0
MRK buys
0
No recent congressional trades found for AKRFF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAKRFFMRK
Forward yield2063.98%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$13331039307.22M$56.8K
Annual income after 10y$12,171,036,297,947,368.00$9,798.13
Total dividends collected$13248903950.40M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AKRFF vs MRK ($10,000, DRIP)

YearAKRFF PortfolioAKRFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$217,098$206,398.35$11,206$366.19+$205.9KAKRFF
2$4,420,028$4,187,732.78$12,650$502.35+$4.41MAKRFF
3$84,412,065$79,682,634.57$14,407$694.19+$84.40MAKRFF
4$1,512,516,762$1,422,195,852.90$16,585$967.82+$1512.50MAKRFF
5$25,434,529,072$23,816,136,137.07$19,342$1,363.89+$25434.51MAKRFF
6$401,507,365,308$374,292,419,200.69$22,913$1,947.19+$401507.34MAKRFF
7$5,951,621,357,208$5,522,008,476,328.59$27,662$2,823.89+$5951621.33MAKRFF
8$82,867,113,366,068$76,498,878,513,854.90$34,159$4,173.35+$82867113.33MAKRFF
9$1,084,114,961,932,747$995,447,150,631,054.80$43,337$6,308.80+$1084114961.89MAKRFF
10$13,331,039,307,215,410$12,171,036,297,947,368.00$56,776$9,798.13+$13331039307.16MAKRFF

AKRFF vs MRK: Complete Analysis 2026

AKRFFStock

Ackroo Inc. develops and sells an online loyalty and rewards platform that enables businesses to design and execute customer transaction, engagement, and retention strategies primarily in North America. It enables small to medium sized businesses to automate the processing and management of gift card and loyalty transactions to increase profitability and build long-term customer relationships. The company's cloud-based marketing platform provides merchants an in-store and online process to manage loyalty, gift card, and promotional transactions at the point of sale; a program to help them view data for reconciliation, reporting, and marketing; and customer interfaces to allow merchant's consumers to register, check, transfer, and reload balances. It also provides AckrooPOS/GGGolf platform for golf clubs, which integrates accounting and hospitality point of sale options and other services; and offers handicapping services, as well as to manage tee-sheets, lottery, and tournaments. In addition, the company offers marketing services, including email and direct mail marketing, and design services; and payment services comprising credit and debit card processing services. It serves automotive, petroleum, hospitality, and retail markets. Ackroo Inc. was founded in 2012 and is headquartered in Hamilton, Canada.

Full AKRFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AKRFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKRFF vs SCHDAKRFF vs JEPIAKRFF vs OAKRFF vs KOAKRFF vs MAINAKRFF vs JNJAKRFF vs ABBVAKRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.